...
首页> 外文期刊>Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists >Treatment of Type IIIb Endoleaks After EVAR Using the Nellix EndoVascular Aneurysm Sealing System
【24h】

Treatment of Type IIIb Endoleaks After EVAR Using the Nellix EndoVascular Aneurysm Sealing System

机译:使用Nellix血管内动脉瘤封闭系统治疗EVAR后IIIb型内渗

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To describe the successful endovascular treatment of 2 patients with type IIIb endoleak using the Nellix EndoVascular Aneurysm Sealing (EVAS) System. Case Report: Two men aged 75 and 83 years presented with type IIIb endoleak several years (8 and 3, respectively) after initial endovascular aneurysm repair. Dual Nellix endoprosthesis were deployed in the stent-grafts, and the endobags were filled with polymer to seal the defect and eliminate the endoleak. The perioperative periods were uneventful. At up to 6-month follow-up, no endoleaks were detected, aneurysm diameters were unchanged, and the endografts were patent. One patient died 7 months after revision due to a metastatic malignancy. Conclusion: The Nellix EVAS System may prove useful for the treatment of type IIIb endoleak.
机译:目的:描述使用Nellix内腔血管瘤封闭(EVAS)系统成功治疗2例IIIb型内漏的血管内方法。病例报告:两名年龄分别为75和83岁的男性在首次血管内动脉瘤修复后数年(分别为8和3)出现IIIb型内渗。将双Nellix内假体部署在支架移植物中,并用聚合物填充内袋以密封缺损并消除内漏。围手术期平稳。在长达6个月的随访中,未发现内漏,动脉瘤直径未改变,并且内移植物已获专利。一名患者在翻修后7个月因转移性恶性肿瘤死亡。结论:Nellix EVAS系统可能被证明可用于治疗IIIb型内漏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号